Article
Genetically Engineered Mouse Models of Brain Cancer and the Promise of Preclinical Testing
3 Dec 2008
Abstract excerpt
Recent improvements in the understanding of brain tumor biology have opened the door to a number of rational therapeutic strategies targeting distinct oncogenic pathways. The successful translation of such "designer drugs" to clinical application depends heavily on effective and expeditious screening methods in relevant disease models. By recapitulating both the underlying genetics and the characteristic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
